Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus
- PMID: 8149036
Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus
Abstract
Five hundred and eighty-five patients with carcinoma of the thoracic esophagus underwent resection of the esophagus in the surgical department in which we work since 1965. The postoperative 30 day mortality rate was 11.9 percent during the early period, from 1965 to 1974, whereas it has decreased to 1.3 percent in the period since 1985. The most common cause of mortality was pulmonary complications (45.8 percent). The five year survival rate of patients who underwent a curative resection between 1975 and 1984 was only 29.1 percent, whereas it has remarkably increased to 49.9 percent since 1985, at which time cervical thoracic and abdominal lymph node dissection began to be regularly performed. There were three patients with intraepithelial carcinoma and 17 with mucosal carcinoma, respectively; none of these patients died within five years postoperatively. However, the five year survival rate of 73 patients with submucosal carcinoma of the esophagus was only 52.6 percent. Thus, it is clear that the prognosis substantially worsens when carcinomatous invasion reaches the submucosal layer. From the results of this study, it can be concluded that a combination of early detection and resection of the esophagus with three field lymph node dissection offers the best chance for long term survival in patients with carcinoma of the esophagus.
Similar articles
-
Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.Am J Surg. 2005 Jan;189(1):98-109. doi: 10.1016/j.amjsurg.2004.10.001. Am J Surg. 2005. PMID: 15701501
-
The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus.Hepatogastroenterology. 2005 Jan-Feb;52(61):105-7. Hepatogastroenterology. 2005. PMID: 15783006
-
[Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].Ai Zheng. 2007 Mar;26(3):307-11. Ai Zheng. 2007. PMID: 17355797 Chinese.
-
New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.Best Pract Res Clin Gastroenterol. 2006;20(5):893-906. doi: 10.1016/j.bpg.2006.03.010. Best Pract Res Clin Gastroenterol. 2006. PMID: 16997168 Review.
-
Surgical treatment of esophageal carcinoma.Gastroenterol Clin North Am. 1991 Dec;20(4):743-63. Gastroenterol Clin North Am. 1991. PMID: 1723970 Review.
Cited by
-
A novel variant of human Grb7 is associated with invasive esophageal carcinoma.J Clin Invest. 1998 Aug 15;102(4):821-7. doi: 10.1172/JCI2921. J Clin Invest. 1998. PMID: 9710451 Free PMC article.
-
Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.Br J Cancer. 1999 Feb;79(3-4):565-9. doi: 10.1038/sj.bjc.6690089. Br J Cancer. 1999. PMID: 10027331 Free PMC article.
-
Guidelines for the management of oesophageal and gastric cancer.Gut. 2002 Jun;50 Suppl 5(Suppl 5):v1-23. doi: 10.1136/gut.50.90005.v1. Gut. 2002. PMID: 12049068 Free PMC article. No abstract available.
-
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.Br J Cancer. 2000 May;82(9):1557-60. doi: 10.1054/bjoc.1999.1178. Br J Cancer. 2000. PMID: 10789724 Free PMC article.
-
Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.Gut. 1996 Jan;38(1):66-70. doi: 10.1136/gut.38.1.66. Gut. 1996. PMID: 8566862 Free PMC article.
MeSH terms
LinkOut - more resources
Medical